-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Maintains Overweight on Abbott Laboratories, Raises Price Target to $133

Benzinga · 01/06/2023 08:37
Morgan Stanley analyst Cecilia Furlong maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $117 to $133.